Jeff Jonas, Sage Therapeutics CEO, discusses a new way to treat postpartum depression. With CNBC's Meg Tirrell.
“My opinion is the best solution for this is not just investigative, it is legislative,” he says.
Prescription drug prices have soared, often exceeding US average annual income. These are the five most expensive. CNBC's Dina Gusovsky reports.
The federal government aims to fight the growing epidemic of opioid abuse in the US.
Mark Crumpacker was named in an indictment linking him to a cocaine delivery service in New York.
CNBC's Jane Wells reports that California voters will get the chance to decide whether to legalize recreational marijuana.
CNBC's Meg Tirrell reports on drug maker Tesaro's experimental ovarian cancer drug successfully slowing the growth of tumors.
At a trilateral press conference in Canada for the North American Leaders' Summit, President Obama speaks about drug epidemics across the continent as well as joint global efforts.
CNBC's Meg Tirrell reports on moves in pharmaceutical stocks including Gilead rising on FDA approval for its new combo hepatitis C pill.
Justin Gover, GW Pharmaceuticals CEO, speaks with CNBC's Meg Tirrell, about the status of regulatory filings for the Dravet syndrome drug Epidiolex and the coming launch for the medication in U.S. as well as Europe.
CNBC's Meg Tirrell reports Europe's drug regulator, the European Medicines Agency, is expected to leave London as a result of the Brexit vote.
CNBC's Eamon Javers reports on entrepreneurs working to keep the cash economy running smoothly in legal marijuana industry.
President Obama has arrived in Orlando, Florida, to meet the families of the victims of the deadly Pulse nightclub shooting; and a drug worked so well in a lung cancer trial that the study was stopped early so the participants could use it, reports CNBC's Sue Herera.
CNBC's Eamon Javers reports Microsoft is adding pot industry software provider "KIND Financial" to its government solutions package.
CNBC's Kate Rogers reports from Denver about a kiosk start-up taking on the marijuana industry.
In a niche where cash is king, one marijuana kiosk start-up wants to improve the sales buzz for retailers and customers. CNBC's Kate Rogers reports.
Despite the drop in the use of painkillers by hurt workers, such medications remain commonly prescribed to them in many states.
Ariad Pharmaceuticals President and CEO Paris Panayiotopoulos, discusses patient response to cancer treatment Brigatinib.
CNBC's Meg Tirrell speaks with Daniel O'Day, Roche Holdings CEO of Pharmaceuticals Division, at the ASCO Conference about the company's cancer drug developments and the state of the pharmaceuticals industry.
A drug resistant bacteria is putting health officials on high alert, in which some are looking at the need for new antibiotics. Ezekiel Emanuel, Center for American Progress, discusses the dangers of over-prescription, and urges creation of new antibiotics.